1 not yet recruiting, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Not yet recruiting 1, Withdrawn 1 |
Follow Haloperidol: new trials by email Literature Review of Haloperidol trials Research Report on Haloperidol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department Haloperidol - Cannabinoid Hyperemesis Syndrome | Early Phase 1 | Not yet recruiting | University of Illinois at Chicago | 100 | 2026-11-01 | 2026-09-01 |
| Evidence of Haloperidol Absorption After Topical Administration Haloperidol, Placebo - Nausea, Vomiting | Early Phase 1 | Withdrawn | Eric E. Prommer | 2012-03-01 | 2016-03-17 |
Cannabinoid Hyperemesis Syndrome (1) · Chediak-Higashi Syndrome (1) · Nausea (1) · Vomiting (1)
Eric E. Prommer (1) · University of Illinois at Chicago (1)
United States (1)
Eric Prommer, MD (1) · Wesley Eilbert, MD (1)